Author： Swen Jesse J Wessels Judith AM Krabben Annemarie Assendelft Willem JJ Guchelaar Henk-Jan
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.11, Iss.11, 2010-11, pp. : 1517-1523
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus
Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. :
Access to resources
Recommend
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. :
The Pharmaceutical care of patients with type 2 diabetes mellitus
By Borges Anna
Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. :
By Ragia Georgia Petridis Ioannis Tavridou Anna Christakidis Dimitrios Manolopoulos Vangelis G
Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. :